249 related articles for article (PubMed ID: 35050692)
1. Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses.
Nguyen LC; Yang D; Nicolaescu V; Best TJ; Gula H; Saxena D; Gabbard JD; Chen SN; Ohtsuki T; Friesen JB; Drayman N; Mohamed A; Dann C; Silva D; Robinson-Mailman L; Valdespino A; Stock L; Suárez E; Jones KA; Azizi SA; Demarco JK; Severson WE; Anderson CD; Millis JM; Dickinson BC; Tay S; Oakes SA; Pauli GF; Palmer KE; ; Meltzer DO; Randall G; Rosner MR
Sci Adv; 2022 Feb; 8(8):eabi6110. PubMed ID: 35050692
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response.
Nguyen LC; Yang D; Nicolaescu V; Best TJ; Ohtsuki T; Chen SN; Friesen JB; Drayman N; Mohamed A; Dann C; Silva D; Gula H; Jones KA; Millis JM; Dickinson BC; Tay S; Oakes SA; Pauli GF; Meltzer DO; Randall G; Rosner MR
bioRxiv; 2021 Mar; ():. PubMed ID: 33758843
[TBL] [Abstract][Full Text] [Related]
3. Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.
Herder V; Dee K; Wojtus JK; Epifano I; Goldfarb D; Rozario C; Gu Q; Da Silva Filipe A; Nomikou K; Nichols J; Jarrett RF; Stevenson A; McFarlane S; Stewart ME; Szemiel AM; Pinto RM; Masdefiol Garriga A; Davis C; Allan J; Graham SV; Murcia PR; Boutell C
PLoS Biol; 2021 Dec; 19(12):e3001065. PubMed ID: 34932557
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Diverges from Other Betacoronaviruses in Only Partially Activating the IRE1α/XBP1 Endoplasmic Reticulum Stress Pathway in Human Lung-Derived Cells.
Nguyen LC; Renner DM; Silva D; Yang D; Parenti NA; Medina KM; Nicolaescu V; Gula H; Drayman N; Valdespino A; Mohamed A; Dann C; Wannemo K; Robinson-Mailman L; Gonzalez A; Stock L; Cao M; Qiao Z; Moellering RE; Tay S; Randall G; Beers MF; Rosner MR; Oakes SA; Weiss SR
mBio; 2022 Oct; 13(5):e0241522. PubMed ID: 36125275
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol and Terpene Formulation Reducing SARS-CoV-2 Infectivity Tackling a Therapeutic Strategy.
Santos S; Barata P; Charmier A; Lehmann I; Rodrigues S; Melosini MM; Pais PJ; Sousa AP; Teixeira C; Santos I; Rocha AC; Baylina P; Fernandes R
Front Immunol; 2022; 13():841459. PubMed ID: 35242142
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19.
Boon ACM; Bricker TL; Fritch EJ; Leist SR; Gully K; Baric RS; Graham RL; Troan BV; Mahoney M; Janetka JW
J Virol; 2024 May; 98(5):e0190323. PubMed ID: 38593045
[TBL] [Abstract][Full Text] [Related]
7. Disparate temperature-dependent virus-host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium.
V'kovski P; Gultom M; Kelly JN; Steiner S; Russeil J; Mangeat B; Cora E; Pezoldt J; Holwerda M; Kratzel A; Laloli L; Wider M; Portmann J; Tran T; Ebert N; Stalder H; Hartmann R; Gardeux V; Alpern D; Deplancke B; Thiel V; Dijkman R
PLoS Biol; 2021 Mar; 19(3):e3001158. PubMed ID: 33780434
[TBL] [Abstract][Full Text] [Related]
8. Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity.
Rand U; Kupke SY; Shkarlet H; Hein MD; Hirsch T; Marichal-Gallardo P; Cicin-Sain L; Reichl U; Bruder D
Cells; 2021 Jul; 10(7):. PubMed ID: 34359926
[TBL] [Abstract][Full Text] [Related]
9. A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection.
Chen F; Shi Q; Pei F; Vogt A; Porritt RA; Garcia G; Gomez AC; Cheng MH; Schurdak ME; Liu B; Chan SY; Arumugaswami V; Stern AM; Taylor DL; Arditi M; Bahar I
Mol Syst Biol; 2021 Aug; 17(8):e10239. PubMed ID: 34339582
[TBL] [Abstract][Full Text] [Related]
10. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
11. Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells.
Wing PAC; Keeley TP; Zhuang X; Lee JY; Prange-Barczynska M; Tsukuda S; Morgan SB; Harding AC; Argles ILA; Kurlekar S; Noerenberg M; Thompson CP; Huang KA; Balfe P; Watashi K; Castello A; Hinks TSC; James W; Ratcliffe PJ; Davis I; Hodson EJ; Bishop T; McKeating JA
Cell Rep; 2021 Apr; 35(3):109020. PubMed ID: 33852916
[TBL] [Abstract][Full Text] [Related]
12. Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19.
Malinowska B; Baranowska-Kuczko M; Kicman A; Schlicker E
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671463
[TBL] [Abstract][Full Text] [Related]
13. Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19.
Mirabelli C; Wotring JW; Zhang CJ; McCarty SM; Fursmidt R; Pretto CD; Qiao Y; Zhang Y; Frum T; Kadambi NS; Amin AT; O'Meara TR; Spence JR; Huang J; Alysandratos KD; Kotton DN; Handelman SK; Wobus CE; Weatherwax KJ; Mashour GA; O'Meara MJ; Chinnaiyan AM; Sexton JZ
Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34413211
[TBL] [Abstract][Full Text] [Related]
14. Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene responses to the SARS-CoV-2 genes ORF8, ORF10 and M protein.
Fernandes MF; Chan JZ; Hung CCJ; Tomczewski MV; Duncan RE
Life Sci; 2022 Jul; 301():120624. PubMed ID: 35568225
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological activation of STING blocks SARS-CoV-2 infection.
Li M; Ferretti M; Ying B; Descamps H; Lee E; Dittmar M; Lee JS; Whig K; Kamalia B; Dohnalová L; Uhr G; Zarkoob H; Chen YC; Ramage H; Ferrer M; Lynch K; Schultz DC; Thaiss CA; Diamond MS; Cherry S
Sci Immunol; 2021 May; 6(59):. PubMed ID: 34010142
[TBL] [Abstract][Full Text] [Related]
16. Interferon-Independent Restriction of RNA Virus Entry and Replication by a Class of Damage-Associated Molecular Patterns.
Ernandes MJ; Kagan JC
mBio; 2021 Apr; 12(2):. PubMed ID: 33849978
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air-Liquid Interface Cultured Human Primary Bronchial Epithelial Cells.
Ter Ellen BM; Dinesh Kumar N; Bouma EM; Troost B; van de Pol DPI; van der Ende-Metselaar HH; Apperloo L; van Gosliga D; van den Berge M; Nawijn MC; van der Voort PHJ; Moser J; Rodenhuis-Zybert IA; Smit JM
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372541
[TBL] [Abstract][Full Text] [Related]
18. Endoplasmic reticulum stress and NF-kB activation in SARS-CoV-2 infected cells and their response to antiviral therapy.
Bartolini D; Stabile AM; Vacca C; Pistilli A; Rende M; Gioiello A; Cruciani G; Galli F
IUBMB Life; 2022 Jan; 74(1):93-100. PubMed ID: 34390301
[TBL] [Abstract][Full Text] [Related]
19. A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection.
Rocha SM; Fagre AC; Latham AS; Cummings JE; Aboellail TA; Reigan P; Aldaz DA; McDermott CP; Popichak KA; Kading RC; Schountz T; Theise ND; Slayden RA; Tjalkens RB
Front Immunol; 2022; 13():811430. PubMed ID: 35250984
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice.
Shang C; Zhuang X; Zhang H; Li Y; Zhu Y; Lu J; Ge C; Cong J; Li T; Tian M; Jin N; Li X
Virol J; 2021 Feb; 18(1):46. PubMed ID: 33639976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
